SETD2 and clear cell renal carcinoma: Therefore, mutations of SETD2 may cause genomic instability, aberrant gene transcription, RNA processing defects, and have impact on multiple biological process that have been associated with the outcome of several types of cancer such as clear cell renal cell carcinoma, glioma, lung and breast cancer [24–26].